Talcum Powder Cancer Lawsuit

Talcum Powder Mesothelioma Study May Have Included Opinions Of Paid Sources

Johnson & Johnson is suing to have a study linking using cosmetic talc and developing mesothelioma publicly retracted claiming the sources may have been paid for their opinion

Sunday, September 10, 2023 - Three more talcum powder cancer researchers are being sued by LTL management, a subsidiary of Johnson & Johnson tasked with dealing with thousands of ovarian cancer and mesothelioma lawsuits. A fourth lawsuit has already been filed against talc ovarian cancer researcher Jacqueline Moline. The lawsuits named researchers Richard Kradin, Theresa Emory, and John Maddox as defendants. The company's reason for the lawsuits is to force the experts to issue a public retraction of their study that points to a link between using talc-based personal care products like Johnson's Baby Powder and Shower to Shower body lotion, and developing mesothelioma, a cancer of the delicate lining of the lungs thought to be fatal. Plaintiff lawyers think that the lawsuits are aimed at quieting important expert witnesses approved by New Jersey judge Freda Wolfson during Daubert hearings several years ago. The company's latest legal action may also be the next step in its defense now that the bid to protect more than 70,000 talcum powder cancer lawsuits through bankruptcy has been denied.

The lawsuits ask a New Jersey federal court judge to force the defendants to "retract and/or issue a correction" of their publications saying that their conclusions are based on junk science meant to disparage the reputation of Johnson & Johnson products. The lawsuit cites the three researchers' co-authored report as the driving factor that forced the company to discontinue selling Johnson's Baby Powder in North America and worldwide. According to ChemistryWorld.com. " US healthcare giant Johnson & Johnson (J&J) has launched a second lawsuit against researchers whose studies have connected talc-based powders and cancer, attacking the underlying science. Earlier this month, J&J's subsidiary LTL Management, which was formed in 2021 to assume the company's liabilities in talc litigation, sued two pathologists affiliated with Peninsula Pathology Associates in Virginia, US -- Theresa Emory and John Maddox -- and Richard Kradin, a pathologist and pulmonologist who is now retired from the Harvard University-affiliated Massachusetts General Hospital Cancer Center." " LTL argues that the paper included false statements, including that cosmetic talc was the only known exposure of the 75 study subjects to asbestos. The company asserts that some individuals in that study had admitted to, and even made claims seeking compensation for, contact with other sources of asbestos. 'The authors knew that or recklessly disregarded substantial evidence to the contrary,' LTL's complaint states," CW writes. Asbestos, a naturally occurring mineral, poses a grave threat to human health when inhaled or ingested, potentially leading to severe and often fatal health consequences. The intricate link between asbestos and talcum powder traces its origins back to the early 1970s, a pivotal period in the quest to understand and mitigate potential health risks associated with consumer products. During this era, scientific investigations began to hint at the possibility of certain talcum powder products being contaminated with asbestos fibers, sparking a profound revelation.

Information provided by TalcumPowderCancerLawsuit.com, a website devoted to providing news about talcum powder ovarian cancer lawsuits, as well as medical research and findings.

More Recent Talcum Powder Ovarian Cancer Lawsuit News:

View all Talcum Powder Cancer Lawsuit News

No-Cost, No-Obligation Baby Powder Lawsuit Case Review for Persons or Families of Persons Who Developed Ovarian Cancer After a History of Perineal Baby Powder Use

OnderLaw, LLC is a St. Louis personal injury law firm handling serious injury and death claims across the country. Its mission is the pursuit of justice, no matter how complex the case or strenuous the effort. The Onder Law Firm has represented clients throughout the United States in pharmaceutical and medical device litigation such as Pradaxa, Lexapro and Yasmin/Yaz, where the firm's attorneys held significant leadership roles in the litigation, as well as Actos, DePuy, Risperdal and others. The firm has represented thousands of persons in these and other products liability litigation, including DePuy hip replacement systems, which settled for $2.5 billion and Pradaxa internal bleeding, which settled for $650 million. The Onder Law Firm won over $300 million in four talcum powder ovarian cancer lawsuits in St. Louis to date and other law firms throughout the nation often seek its experience and expertise on complex litigation.


Privacy Notice: This site uses cookies for advertising, analytics and to improve our site services. By continuing to use our site, you agree to our use of cookies. For more information, see our cookie and privacy policy.